Effect of Dexmedetomidine and Sufentanil on the Quality of Postoperative Pain of Patients After Video Assisted Thoracic Surgery: a Prospective, Randomized, Controlled Trial

Effect of Dexmedetomidine and Sufentanil on the Quality of Postoperative Pain of Patients After Video Assisted Thoracic Surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000028958

Enrollment

Unknown

Registered

2020-01-09

Start date

2020-01-15

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

S group:sufentanil

D group:dexmedetomidine+sufentanil

Eligibility

Sex/Gender

Male

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. ASA II~III; 2. Age: 30~65 years; 3. Patients undergoing video-assisted thoracic.

Exclusion criteria

Exclusion criteria: 1. Body mass index>30 kg/m2; 2. Severe heart lung, liver kidney and other organ diseases; 3. Use of antihypertensive drugs or beta adrenergic receptor blocker before surgery (>3 months); 4. Be allergic to sufentanil or dexmedetomidine; 5. A history of chronic pain and the long-term use of analgesic drugs (>3 months).

Design outcomes

Primary

Measure	Time frame
the scores of pain;the scores of pain;sufentanil consumption.;the scores of sedation;Adverse reactions;Adverse reactions;	—

Countries

China

Contacts

Public ContactLi Zhang

Department of Anesthesiology, Kunshan Hospital Affiliated to Jiangsu Medical University

505336562@qq.com+86 13862630409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026